Dr Charles Chiedza Maponga is a clinical Pharmacist who holds a Bachelor of Pharmacy Degree (B.Pharm(Hons)) from the University of Zimbabwe (UZ), a doctorate degree in Pharmacy (PharmD) from the State University of New York (SUNY-Buffalo) and a Masters in Health Professions Education (MHPE) from the University of Illinois at Chicago (UIC).
Dr. Maponga is Senior Lecturer and Director of the School of Pharmacy in the University of Zimbabwe’s College of Health Sciences (UZ-CHS) and is the Program Director for the International Pharmacotherapy Education and Research (IPERI). IPERI is an initiative of SUNY-Buffalo’s School of Pharmacy and Pharmaceutical Sciences and the UZ-School of Pharmacy which links the two institutions to advance HIV Clinical Pharmacology research.
Dr. Maponga is also a special projects advisory member to the Medicines Control Authority Zimbabwe and a member of the Pharmacists Council of Zimbabwe who chairs the Pharmacists Council’s Education and Liaison Committee.
Dr Maponga is research team member and Pharmacy Consultant for the University of Zimbabwe and University of California at San Francisco’s collaborative research program in women’s health where he provides advice on Pharmacy related issues. He has extensive training and skills in the implementation of antiretroviral medication.
Dr Maponga has been actively involved in the Adult Clinical Trials Group (ACTG)’s Pharmacology Committee and has been a protocol pharmacologist in several ACTG studies. His ACTG involvement has been partly through his linkage with the School of Pharmacy of the State University of New York at Buffalo where he holds the position of visiting International HIV Pharmacology Research Scientist.
He is co-Principal Investigator in a recently awarded NIH Fogarty International Center’s AIDS International Training and Research Program (AITRP) grant to develop HIV Clinical Pharmacology Research Programs in southern Africa.